New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport

American Journal of Cardiology

Volumn 91, Issue 7 SUPPL. 1, 2003, Pages 3-11

  Brewer Jr , H Bryan ^a   Santamarina Fojo, Silvia ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ABCA1 GENE; ABCG1 GENE; ABCG5 GENE; ABCG8 GENE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; GENE; GENE CASSETTE; GENE OVEREXPRESSION; HUMAN; INTESTINE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER; MACROPHAGE; NONHUMAN; PLANT; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SHELLFISH; TRANSGENIC MOUSE;

EID: 0037417245     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03382-9     Document Type: Conference Paper

References (39)

1. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 113:1987;589-597.
2. Gordon D.J., Rifkind B.M. High-density lipoprotein - the clinical implications of recent studies. N Engl J Med. 321:1989;1311-1316.
3. Glomset J.A. The plasma lecithins cholesterol acyltransferase reaction . J Lipid Res. 9:1968;155-167.
4. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J Lipid Res. 38:1997;1503-1505.
5. Oram J.F., Vaughan A.M. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol. 11:2000;253-260.
6. Yancey P.G., de la Llera-Moya M., Swarnakar S., Monzo P., Klein S.M., Connelly M.A., Johnson W.J., Williams D.L., Rothblat G.H. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem. 275:2000;36596-36604.
7. Williams DL, Connelly MA, Temel RE, Swarnakar S, Phillips MC, de la Llera-Moya M, Rothblat GH. Scavenger receptor BI and cholesterol trafficking. Curr Opin Lipidol 1999;10:329-339.
8. Assman G, von Eckardstein A, Brewer HB Jr. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw Hill, 2001:2937-2980.
9. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 22:1999;336-345.
10. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 22:1999;347-351.
11. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denefle P., Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 22:1999;352-355.
12. Remaley A.T., Rust S., Rosier M., Knapper C., Naudin L., Broccardo C., Peterson K.M., Koch C., Arnould I., Prades C., et al. Human ATP-binding cassette transporter 1 (ABC1) genomic organization and identification of the genetic defect in the original Tangier disease kindred . Proc Natl Acad Sci USA. 96:1999;12685-12690.
13. Brousseau M.E., Schaefer E.J., Dupuis J., Eustace B., Van Eerdewegh P., Goldkamp A.L., Thurston L.M., FitzGerald M.G., Yasek-McKenna D., O'Neill G., et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds. J Lipid Res. 41:2000;433-441.
14. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 104:1999;R25-R31.
15. Bortnick A.E., Rothblat G.H., Stoudt G., Hoppe K.L., Royer L.J., McNeish J., Francone O.L. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem. 275:2000;28634-28640.
16. Orso E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W., Gotz A., Chambenoit O., Diederich W., Langmann T., et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat Genet. 24:2000;192-196.
17. Wang N., Silver D.L., Thiele C., Tall A.R. ATP-binding cassette transporter Al (ABCAl) functions as a cholesterol efflux regulatory protein. J Biol Chem. 276:2001;23742-23747.
18. Neufeld E.B., Remaley A.T., Demosky S.J., Stonik J.A., Cooney A.M., Comly M., Dwyer N.K., Zhang M., Blanchette-Mackie J., Santamarina-Fojo S., Brewer H.B. Jr. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem. 276:2001;27584-27590.
19. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., Hoppe K.L., Roach M.L., Royer L.J., de Wet J., et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA. 97:2000;4245-4250.
20. Christiansen-Weber T.A., Voland J.R., Wu Y., Ngo K., Roland B.L., Nguyen S., Peterson P.A., Fung-Leung W.P. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol. 157:2000;1017-1029.
21. Vaisman B.L., Lambert G., Amar M., Joyce C., Ito T., Shamburek R.D., Cain W.J., Fruchart-Najib J., Neufeld E.D., Remaley A.T., Brewer H.B. Jr, Santamarina-Fojo S. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest. 108:2001;303-309.
22. Joyce C.W., Amar M.J., Lambert G., Vaisman B.L., Paigen B., Najib-Fruchart J., Hoyt R.F. Jr, Neufeld E.D., Remaley A.T., Fredrickson D.S., Brewer H.B. Jr, Santamarina-Fojo S. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA. 99:2002;407-412.
23. Haghpassand M., Bourassa P.A., Francone O.L., Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest. 108:2001;1315-1320.
24. Neufeld E.B., Demosky S.J., Stonik J.A., Combs C., Remaley A.T., Duverger N., Santamarina-Fojo S., Brewer H.B. Jr. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem Biophys Res Comm. 297:2002;974-979.
25. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld EB, Tansey T, Amar MJA, Fruchart-Najib J, Duverger N, et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL-cholesterol concentrations. J Lipid Res 2003;44:296-302.
26. Klucken J., Büchler C., Orsó E., Kaminski W.E., Porsch-Özcürümez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA. 97:2000;817-822.
27. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA. 98:2001;507-512.
28. Schmitz G., Langmann T., Heomerl S. Role of ABCGI and other ABCG family members in lipid metabolism. J Lipid Res. 42:2001;1513-1520.
29. Ito T, Sabol S, Amar M, Knapper C, Duarte C, Shamburek RD, Meyn S, Santamarina-Fojo S, Brewer HB Jr. Adenovirus-mediated expression establishes an in vivo role for human ABCG1 (ABC8) in lipoprotein metabolism. Circulation 2000;102(18 suppl):II-311. Abstract 1525.
30. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290:2000;1771-1775.
31. Lu K., Lee M.H., Hazard S., Brooks-Wilson A., Hidaka H., Kojima H., Ose L., Stalenhoef A.F., Mietinnen T., Bjorkhem I., et al. Two genes that map to the STSL locus cause sitosterolemia genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively . Am J Hum Genet. 69:2001;278-290.
32. Shulenin S., Schriml L.M., Remaley A.T., Fojo S., Brewer B., Allikmets R., Dean M. An ATP-binding cassette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the sitosterolemia locus. Cytogenet Cell Genet. 92:2001;204-208.
33. Lee M.-H., Lu K., Patel S.B. Genetic basis of sitosterolemia. Curr Opin Lipidol. 12:2001;141-149.
34. Bhattacharyya A.K., Connor W.E., Lin D.S., McMurry M.M., Shulman R.S. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis. Arterioscler Thromb. 11:1991;1287-1294.
35. Gregg R.E., Connor W.E., Lin D.S., Brewer H.B. Jr. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J Clin Invest. 77:1986;1864-1872.
36. Salen G., Shore V., Tint G.S., Forte T., Shefer S., Horak I., Horak E., Dayal B., Nguyen L., Batta A.K., et al. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res. 30:1989;1319-1330.
37. Nguyen L.B., Shefer S., Salen G., Ness G.C., Tint G.S., Zaki F.G., Rani I. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. J Clin Invest. 86:1990;923-931.
38. 7-reductase in liver and mononuclear leukocytes . J Lipid Res. 39:1998;44-50.
39. van Heek M., Farley C., Compton D.S., Hoos L., Alton K.B., Sybertz E.J., Davis H.R. Jr. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol. 129:2000;1748-1754.